蒽环类药物对阿霉素（NSC - 123127）耐药的P388白血病亚系的活性，特别着重于烬灰红菌素A（NSC - 18334）。 - Suppr

Suppr

超能文献

Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).

作者信息

Johnson R K, Ovejera A A, Goldin A

出版信息

Cancer Treat Rep. 1976 Jan;60(1):99-102.

PMID:826316

Abstract

摘要

相似文献

Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).蒽环类药物对阿霉素（NSC - 123127）耐药的P388白血病亚系的活性，特别着重于烬灰红菌素A（NSC - 18334）。

Cancer Treat Rep. 1976 Jan;60(1):99-102.

In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.P388白血病阿霉素耐药亚系的体内耐药及交叉耐药特性

Cancer Treat Rep. 1978 Oct;62(10):1535-47.

Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.大分子霉素B（NSC 170105）对小鼠白血病、黑色素瘤和肺癌的抗肿瘤活性。

Cancer Res. 1975 Apr;35(4):939-45.

Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.新型蒽基双腙9,10-蒽二甲醛双[(4,5-二氢-1H-咪唑-2-基)腙]二盐酸盐对小鼠实验性肿瘤的活性

Cancer Res. 1982 Feb;42(2):440-4.

[Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].[卡米诺霉素和柔红霉素抗白血病活性的比较实验研究]

Antibiotiki. 1977 Sep;22(9):846-52.

[Models of preclinical studies of anthracyclines].[蒽环类药物的临床前研究模型]

Pathol Biol (Paris). 1987 Jan;35(1):41-8.

Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.新型双腙桥联4-去甲氧基柔红霉素衍生物SC33428对小鼠实验性肿瘤的活性

Cancer Res. 1983 Jun;43(6):2880-3.

Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).通过与顺二氨二氯铂（NSC - 119875）或柔红霉素（NSC - 82151）联合使用增强ICRF - 159（NSC - 129943）对早期L1210白血病的抗肿瘤效果。

Cancer Chemother Rep 2. 1974 Mar;4(1):45-52.

MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.MX2，一种吗啉代蒽环类药物，作为一种针对药物敏感和多药耐药的人类及小鼠肿瘤细胞的新型抗肿瘤药物。

Cancer Res. 1988 Dec 1;48(23):6653-7.

Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.阿霉素和柔红霉素：免疫抑制后小鼠体内抗肿瘤活性及组织摄取的比较

Cancer Res. 1973 Aug;33(8):1837-44.

引用本文的文献

5'-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells.阿霉素敏感和耐药的P388细胞中的5'-核苷酸酶活性与花生四烯酸代谢

Br J Cancer. 1984 Apr;49(4):447-51. doi: 10.1038/bjc.1984.71.

Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.在多柔比星耐药的P388小鼠白血病亚系中对甲氨蝶呤酯的交叉耐药性。

Cancer Chemother Pharmacol. 1985;15(1):31-4. doi: 10.1007/BF00257290.

The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.C6和9L大鼠胶质瘤阿霉素耐药亚系中的耐药机制及耐药克服

J Neurooncol. 1987;5(3):195-203. doi: 10.1007/BF00151222.

Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.人肺癌细胞阿霉素耐药系的衍生及初步特性分析

Br J Cancer. 1986 Apr;53(4):529-37. doi: 10.1038/bjc.1986.83.

Tumour cell resistance to anthracyclines--a review.

Cancer Chemother Pharmacol. 1985;14(2):96-103. doi: 10.1007/BF00434344.

Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line.

Cancer Chemother Pharmacol. 1990;26(4):250-6. doi: 10.1007/BF02897225.

Structural modification study of anthracyclinones: synthesis and biological activity of several derivatives of eta-pyrromycinone.

Pharm Res. 1992 Jun;9(6):739-42. doi: 10.1023/a:1015891102895.

Anthracyclines--modern tumour-inhibiting agents.

Folia Microbiol (Praha). 1978;23(2):152-61. doi: 10.1007/BF02915316.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验